APO Research

APO RESEARCH · REPORT

Microbial Single-Cell Sequencing

Selected research

Market Outlook & Growth Opportunities

Global Microbial Single-Cell Sequencing Market Outlook and Growth Opportunities 2026

Market perspective

The global Microbial Single-Cell Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Microbial Single-Cell Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Microbial Single-Cell Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microbial Single-Cell Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Microbial Single-Cell Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Microbial Single-Cell Sequencing market include Illumina, 10x Genomics, Pacific Biosciences, Oxford Nanopore Technologies, Beijing Genomic Institute and MobiDrop, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Microbial Single-Cell Sequencing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microbial Single-Cell Sequencing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microbial Single-Cell Sequencing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Microbial Single-Cell Sequencing market.

Microbial Single-Cell Sequencing Segment by Company

Illumina

10x Genomics

Pacific Biosciences

Oxford Nanopore Technologies

Beijing Genomic Institute

MobiDrop

Microbial Single-Cell Sequencing Segment by Type

Genome Sequencing

Transcriptome Sequencing

Metagenome Sequencing

Others

Microbial Single-Cell Sequencing Segment by Application

Food Industry

Environmental Monitoring

Pharmaceutical Industry

Microbial Single-Cell Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Microbial Single-Cell Sequencing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Microbial Single-Cell Sequencing key companies, revenue, market share, and recent developments.

3. To split the Microbial Single-Cell Sequencing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Microbial Single-Cell Sequencing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Microbial Single-Cell Sequencing significant trends, drivers, influence factors in global and regions.

6. To analyze Microbial Single-Cell Sequencing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbial Single-Cell Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microbial Single-Cell Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbial Single-Cell Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microbial Single-Cell Sequencing industry.

Chapter 3: Detailed analysis of Microbial Single-Cell Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Microbial Single-Cell Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Microbial Single-Cell Sequencing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Microbial Single-Cell Sequencing Industry Trends Table 2. Microbial Single-Cell Sequencing Industry Drivers Table 3. Microbial Single-Cell Sequencing Industry Opportunities and Challenges Table 4. Microbial Single-Cell Sequencing Industry Restraints Table 5. Global Microbial Single-Cell Sequencing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Microbial Single-Cell Sequencing Revenue Share by Company (2021-2026) Table 7. Global Microbial Single-Cell Sequencing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Microbial Single-Cell Sequencing Key Company Manufacturing Base & Headquarters Table 9. Global Microbial Single-Cell Sequencing Company, Product Type & Application Table 10. Global Microbial Single-Cell Sequencing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Microbial Single-Cell Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Genome Sequencing Table 15. Significant Companies of Transcriptome Sequencing Table 16. Significant Companies of Metagenome Sequencing Table 17. Significant Companies of Others Table 18. Global Microbial Single-Cell Sequencing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Microbial Single-Cell Sequencing Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Microbial Single-Cell Sequencing Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Microbial Single-Cell Sequencing Sales Value Share by Type (2021-2026) Table 22. Global Microbial Single-Cell Sequencing Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Food Industry Table 24. Significant Companies of Environmental Monitoring Table 25. Significant Companies of Pharmaceutical Industry Table 26. Global Microbial Single-Cell Sequencing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Microbial Single-Cell Sequencing Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Microbial Single-Cell Sequencing Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Microbial Single-Cell Sequencing Sales Value Share by Application (2021-2026) Table 30. Global Microbial Single-Cell Sequencing Sales Value Share by Application (2027-2032) Table 31. Global Microbial Single-Cell Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Microbial Single-Cell Sequencing Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Microbial Single-Cell Sequencing Sales Value Share by Region (2021-2026) Table 34. Global Microbial Single-Cell Sequencing Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Microbial Single-Cell Sequencing Sales Value Share by Region (2027-2032) Table 36. Global Microbial Single-Cell Sequencing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Microbial Single-Cell Sequencing Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Microbial Single-Cell Sequencing Sales Value Market Share by Country (2021-2026) Table 39. Global Microbial Single-Cell Sequencing Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Microbial Single-Cell Sequencing Sales Value Market Share by Country (2027-2032) Table 41. Illumina Company Information Table 42. Illumina Business Overview Table 43. Illumina Microbial Single-Cell Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Illumina Microbial Single-Cell Sequencing Product Portfolio Table 45. Illumina Recent Development Table 46. 10x Genomics Company Information Table 47. 10x Genomics Business Overview Table 48. 10x Genomics Microbial Single-Cell Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. 10x Genomics Microbial Single-Cell Sequencing Product Portfolio Table 50. 10x Genomics Recent Development Table 51. Pacific Biosciences Company Information Table 52. Pacific Biosciences Business Overview Table 53. Pacific Biosciences Microbial Single-Cell Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Pacific Biosciences Microbial Single-Cell Sequencing Product Portfolio Table 55. Pacific Biosciences Recent Development Table 56. Oxford Nanopore Technologies Company Information Table 57. Oxford Nanopore Technologies Business Overview Table 58. Oxford Nanopore Technologies Microbial Single-Cell Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Oxford Nanopore Technologies Microbial Single-Cell Sequencing Product Portfolio Table 60. Oxford Nanopore Technologies Recent Development Table 61. Beijing Genomic Institute Company Information Table 62. Beijing Genomic Institute Business Overview Table 63. Beijing Genomic Institute Microbial Single-Cell Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Beijing Genomic Institute Microbial Single-Cell Sequencing Product Portfolio Table 65. Beijing Genomic Institute Recent Development Table 66. MobiDrop Company Information Table 67. MobiDrop Business Overview Table 68. MobiDrop Microbial Single-Cell Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. MobiDrop Microbial Single-Cell Sequencing Product Portfolio Table 70. MobiDrop Recent Development Table 71. Research Programs/Design for This Report Table 72. Authors List of This Report Table 73. Secondary Sources Table 74. Primary Sources List of Figures Figure 1. Microbial Single-Cell Sequencing Product Image Figure 2. Global Microbial Single-Cell Sequencing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microbial Single-Cell Sequencing Market Size (2021-2032) & (US$ Million) Figure 4. Global Microbial Single-Cell Sequencing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Genome Sequencing Image Figure 8. Transcriptome Sequencing Image Figure 9. Metagenome Sequencing Image Figure 10. Others Image Figure 11. Global Microbial Single-Cell Sequencing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Microbial Single-Cell Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Microbial Single-Cell Sequencing Sales Value Share by Type (2021-2032) Figure 14. Food Industry Image Figure 15. Environmental Monitoring Image Figure 16. Pharmaceutical Industry Image Figure 17. Global Microbial Single-Cell Sequencing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Microbial Single-Cell Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Microbial Single-Cell Sequencing Sales Value Share by Application (2021-2032) Figure 20. Global Microbial Single-Cell Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Microbial Single-Cell Sequencing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Microbial Single-Cell Sequencing Sales Value (2021-2032) & (US$ Million) Figure 23. North America Microbial Single-Cell Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Microbial Single-Cell Sequencing Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Microbial Single-Cell Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Microbial Single-Cell Sequencing Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Microbial Single-Cell Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Microbial Single-Cell Sequencing Sales Value (2021-2032) & (US$ Million) Figure 29. South America Microbial Single-Cell Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Microbial Single-Cell Sequencing Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Microbial Single-Cell Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Genome Sequencing
  • Transcriptome Sequencing
  • Metagenome Sequencing
  • Others
Applications
  • Food Industry
  • Environmental Monitoring
  • Pharmaceutical Industry
Companies covered
  • Illumina
  • 10x Genomics
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Beijing Genomic Institute
  • MobiDrop

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Microbial Single-Cell Sequencing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Microbial Single-Cell Sequencing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Microbial Single-Cell Sequencing Market Dynamics
  1. 2.1 Microbial Single-Cell Sequencing Industry Trends
  2. 2.2 Microbial Single-Cell Sequencing Industry Drivers
  3. 2.3 Microbial Single-Cell Sequencing Industry Opportunities and Challenges
  4. 2.4 Microbial Single-Cell Sequencing Industry Restraints
3 Microbial Single-Cell Sequencing Market by Company
  1. 3.1 Global Microbial Single-Cell Sequencing Company Revenue Ranking in 2025
  2. 3.2 Global Microbial Single-Cell Sequencing Revenue by Company (2021-2026)
  3. 3.3 Global Microbial Single-Cell Sequencing Company Ranking (2024-2026)
  4. 3.4 Global Microbial Single-Cell Sequencing Company Manufacturing Base and Headquarters
  5. 3.5 Global Microbial Single-Cell Sequencing Company Product Type and Application
  6. 3.6 Global Microbial Single-Cell Sequencing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Microbial Single-Cell Sequencing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Microbial Single-Cell Sequencing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Microbial Single-Cell Sequencing Market by Type
  1. 4.1 Microbial Single-Cell Sequencing Type Introduction
  2. 4.1.1 Genome Sequencing
  3. 4.1.2 Transcriptome Sequencing
  4. 4.1.3 Metagenome Sequencing
  5. 4.1.4 Others
  6. 4.2 Global Microbial Single-Cell Sequencing Sales Value by Type
  7. 4.2.1 Global Microbial Single-Cell Sequencing Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Microbial Single-Cell Sequencing Sales Value by Type (2021-2032)
  9. 4.2.3 Global Microbial Single-Cell Sequencing Sales Value Share by Type (2021-2032)
5 Microbial Single-Cell Sequencing Market by Application
  1. 5.1 Microbial Single-Cell Sequencing Application Introduction
  2. 5.1.1 Food Industry
  3. 5.1.2 Environmental Monitoring
  4. 5.1.3 Pharmaceutical Industry
  5. 5.2 Global Microbial Single-Cell Sequencing Sales Value by Application
  6. 5.2.1 Global Microbial Single-Cell Sequencing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Microbial Single-Cell Sequencing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Microbial Single-Cell Sequencing Sales Value Share by Application (2021-2032)
6 Microbial Single-Cell Sequencing Regional Value Analysis
  1. 6.1 Global Microbial Single-Cell Sequencing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Microbial Single-Cell Sequencing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Microbial Single-Cell Sequencing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Microbial Single-Cell Sequencing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Microbial Single-Cell Sequencing Sales Value (2021-2032)
  7. 6.3.2 North America Microbial Single-Cell Sequencing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Microbial Single-Cell Sequencing Sales Value (2021-2032)
  10. 6.4.2 Europe Microbial Single-Cell Sequencing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Microbial Single-Cell Sequencing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Microbial Single-Cell Sequencing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Microbial Single-Cell Sequencing Sales Value (2021-2032)
  16. 6.6.2 South America Microbial Single-Cell Sequencing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Microbial Single-Cell Sequencing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Microbial Single-Cell Sequencing Sales Value Share by Country, 2025 VS 2032
7 Microbial Single-Cell Sequencing Country-level Value Analysis
  1. 7.1 Global Microbial Single-Cell Sequencing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Microbial Single-Cell Sequencing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Microbial Single-Cell Sequencing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Microbial Single-Cell Sequencing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Microbial Single-Cell Sequencing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Microbial Single-Cell Sequencing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Microbial Single-Cell Sequencing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Illumina
  2. 8.1.1 Illumina Company Information
  3. 8.1.2 Illumina Business Overview
  4. 8.1.3 Illumina Microbial Single-Cell Sequencing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Illumina Microbial Single-Cell Sequencing Product Portfolio
  6. 8.1.5 Illumina Recent Developments
  7. 8.2 10x Genomics
  8. 8.2.1 10x Genomics Company Information
  9. 8.2.2 10x Genomics Business Overview
  10. 8.2.3 10x Genomics Microbial Single-Cell Sequencing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 10x Genomics Microbial Single-Cell Sequencing Product Portfolio
  12. 8.2.5 10x Genomics Recent Developments
  13. 8.3 Pacific Biosciences
  14. 8.3.1 Pacific Biosciences Company Information
  15. 8.3.2 Pacific Biosciences Business Overview
  16. 8.3.3 Pacific Biosciences Microbial Single-Cell Sequencing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pacific Biosciences Microbial Single-Cell Sequencing Product Portfolio
  18. 8.3.5 Pacific Biosciences Recent Developments
  19. 8.4 Oxford Nanopore Technologies
  20. 8.4.1 Oxford Nanopore Technologies Company Information
  21. 8.4.2 Oxford Nanopore Technologies Business Overview
  22. 8.4.3 Oxford Nanopore Technologies Microbial Single-Cell Sequencing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Oxford Nanopore Technologies Microbial Single-Cell Sequencing Product Portfolio
  24. 8.4.5 Oxford Nanopore Technologies Recent Developments
  25. 8.5 Beijing Genomic Institute
  26. 8.5.1 Beijing Genomic Institute Company Information
  27. 8.5.2 Beijing Genomic Institute Business Overview
  28. 8.5.3 Beijing Genomic Institute Microbial Single-Cell Sequencing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Beijing Genomic Institute Microbial Single-Cell Sequencing Product Portfolio
  30. 8.5.5 Beijing Genomic Institute Recent Developments
  31. 8.6 MobiDrop
  32. 8.6.1 MobiDrop Company Information
  33. 8.6.2 MobiDrop Business Overview
  34. 8.6.3 MobiDrop Microbial Single-Cell Sequencing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MobiDrop Microbial Single-Cell Sequencing Product Portfolio
  36. 8.6.5 MobiDrop Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research